# Ticagrelor Monotherapy After Stenting

> **NCT05149560** · PHASE2 · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 200 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Ticagrelor 90mg

## Key facts

- **NCT ID:** NCT05149560
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-14
- **Primary completion:** 2025-06-26
- **Final completion:** 2025-06-26
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149560, "Ticagrelor Monotherapy After Stenting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05149560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*